早产儿纯人乳饮食对早期血管老化风险因素的影响:NEOVASC试验方案
NEOVASC为多中心前瞻性随机对照开放平行组试验,在四家奥地利三级新生儿机构开展,比较200例早产儿 prolonged 纯人乳饮食与100例足月儿及历史对照组,评估校正年龄5岁时空腹血糖、血压及降主动脉扩张性等心血管代谢风险因素。
要点
- 早产儿纯人乳饮食(去除牛乳成分)可能减轻早产对心血管风险因素早期发展的不良影响。
- 主要结局为校正年龄5岁时空腹血糖、血压及降主动脉扩张性。
- 试验设足月儿对照组和历史对照组,早产儿试验组200例。
核心结论
- NEOVASC试验旨在验证早产儿 prolonged 纯人乳饮食能否减轻早产对心血管风险因素早期发展的有害影响。
研究设计与样本
- 多中心、前瞻性、随机、对照、开放、平行组临床试验,在四家奥地利三级新生儿护理机构开展。
- 早产儿试验组200例,与100例足月儿对照组及既往招募的历史对照组比较。
关键数值与推荐
- 主要结局包括校正年龄5岁时空腹血糖水平、血压水平及采用经验证超声心动图方案评估的降主动脉扩张性。
- 评估时间点为校正年龄1岁、2岁和5岁。
临床怎么用
- 通过去除牛乳基食品成分优化早产儿营养,可能成为减轻远期心血管代谢风险的干预方向。
局限性
- 本研究为试验方案报告,尚未提供干预效果的结果数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preterm birth accounts for approximately 11% of all livebirths globally. Due to improvements in perinatal care, more than 95% of these infants now survive into adulthood. Research has indicated a robust association between prematurity and increased cardiovascular risk factors and cardiovascular mortality. While the innate adverse effects of prematurity on these outcomes have been demonstrated, therapeutic strategies on the mitigation of these concerning developments are lacking. The primary objective of the NEOVASC clinical trial is therefore to investigate whether the administration of a prolonged exclusive human-milk diet in preterm infants is capable of alleviating the harmful effects of preterm birth on the early development of cardiovascular risk factors. METHODS: The NEOVASC study is a multicentric, prospective, randomized, controlled, open, and parallel group clinical trial conducted in four Austrian tertiary neonatal care facilities. The purpose of the present trial is to investigate the effects of a prolonged exclusive human-milk-diet devoid of bovine-milk-based food components on cardiovascular and metabolic risk factors at 1, 2, and 5 years of corrected age. Primary outcomes include assessments of fasting blood glucose levels, blood pressure levels, and the distensibility of the descending aorta using validated echocardiographic protocols at 5 years of corrected age. The test group, which consists of 200 preterm infants, will therefore be compared to a control group of 100 term-born infants and a historical control group recruited previously. DISCUSSION: Given the emerging implications of an increased cardiovascular risk profile in the potentially growing population of preterm infants, further research on the mitigation of long-term morbidities in formerly preterm infants is urgently warranted. Further optimizing preterm infants' nutrition by removing bovine-milk-based food components may therefore be an interesting approach worth pursuing. TRIAL REGISTRATION: ClinicalTrials.gov NCT04413994 . Registered on 4 June 2020.
引用
- Mitterer W, Binder C, Blassnig-Ezeh A, et al. Effects of an exclusive human-milk diet in preterm neonates on early vascular aging risk factors (NEOVASC): study protocol for a multicentric, prospective, randomized, controlled, open, and parallel group clinical trial. Trials. 2021. PMID: 34332629. doi:10.1186/s13063-021-05445-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。